Your browser doesn't support javascript.
loading
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.
Srimongkol, Atthapol; Laosillapacharoen, Natanan; Saengwimol, Duangporn; Chaitankar, Vijender; Rojanaporn, Duangnate; Thanomchard, Thanastha; Borwornpinyo, Suparerk; Hongeng, Suradej; Kaewkhaw, Rossukon.
Afiliación
  • Srimongkol A; Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
  • Laosillapacharoen N; Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
  • Saengwimol D; Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
  • Chaitankar V; Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Rojanaporn D; Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
  • Thanomchard T; Ramathibodi Comprehensive Cancer Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
  • Borwornpinyo S; Excellent Center for Drug Discovery, Faculty of Science, Mahidol University, 10400, Bangkok, Thailand.
  • Hongeng S; Department of Biotechnology, Faculty of Science, Mahidol University, 10400, Bangkok, Thailand.
  • Kaewkhaw R; Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 10400, Bangkok, Thailand.
J Exp Clin Cancer Res ; 42(1): 39, 2023 Feb 01.
Article en En | MEDLINE | ID: mdl-36726110

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinoblastoma / Neoplasias de la Retina / Antineoplásicos Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinoblastoma / Neoplasias de la Retina / Antineoplásicos Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Reino Unido